⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PDSB News
PDS Biotechnology Corporation Common Stock
PDS Biotech Announces Presentation of Preliminary Results from Phase 2 Study of IL-12 Tumor Targeted Immunocytokine (PDS01ADC) in 3rd Line Metastatic Castration Resistant Prostate Cancer by the NCI
globenewswire.com
PDSB
PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101
globenewswire.com
PDSB
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026
prnewswire.com
ONCY
CGON
ZNTL
AVBP
PDSB
PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint
globenewswire.com
PDSB
PDS Biotech Announces New Composition of Matter Patent for PDS0101 in Japan
globenewswire.com
PDSB
PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration (“FDA”)
globenewswire.com
PDSB
PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
globenewswire.com
PDSB
PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering
globenewswire.com
PDSB
PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
globenewswire.com
PDSB
PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
globenewswire.com
PDSB